Prostate volume correlates with diabetes in elderly benign prostatic hyperplasia patients

By Qu Xiaobing   Huang Zhichao   Meng Xianqin   Zhang Xiangyu   Dong Lini   Zhao Xiaokun  

International Urology and Nephrology, Vol. 46, Iss. 3, 2014-03 ,pp. : 499-504

Springer Publishing Company

Access to resources Recommend Favorite

Increased Bladder Apoptosis with α-1 Adrenoceptor Antagonists in Benign Prostatic Hyperplasia

By Erdoğru T.   Gülkesen K. H.   Kukul E.   Yalçinkaya M.   Karpuzoğlu G.   Baykara M.  

Scandinavian Journal of Urology and Nephrology, Vol. 36, Iss. 3, 2002-06 ,pp. : 188-193

Informa Healthcare

Access to resources Recommend Favorite

Long-term treatment and prognostic factors of α₁-blockers for lower urinary tract symptoms associated with benign prostatic hyperplasia: A pilot study comparing naftopidil and tamsulosin hydrochloride

By Kawachi Yoshio   Sakurai Toru   Sugimura Sosuke   Iwata Shinji   Noto Kensho   Honda Shin-Ichi   Maruyama Osamu  

Scandinavian Journal of Urology and Nephrology, Vol. 44, Iss. 1, 2010-02 ,pp. : 38-45

Informa Healthcare

Access to resources Recommend Favorite

Symptoms, prostate volume, and urodynamic findings in elderly male volunteers without and with LUTS and in patients with LUTS suggestive of benign prostatic hyperplasia

By Eckhardt M.D.   van Venrooij G.E.P.M.   Boon T.A.  

Urology, Vol. 58, Iss. 6, 2001-12 ,pp. : 966-971

Elsevier

Access to resources Recommend Favorite

Short-term efficacy and long-term compliance/treatment failure of the α1 blocker naftopidil for patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia

By Masumori Naoya   Hashimoto Jiro   Itoh Naoki   Tsukamoto Taiji   Group The Sapporo Medical University Naftopidil Study  

Scandinavian Journal of Urology and Nephrology, Vol. 41, Iss. 5, 2007-01 ,pp. : 422-429

Informa Healthcare

Access to resources Recommend Favorite